BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
FDA Grants Kamada Ltd. (KMDA) Orphan Drug Designation For The Treatment Of Graft Versus Host Disease 10/29/2014 8:39:28 AM
Kamada Ltd. (KMDA) Announces Study In Support Of Alpha-1 Antitrypsin For The Treatment Of Type-1 Diabetes Published In The Journal Of Diabetes Science And Technology 10/21/2014 11:06:15 AM
Kamada Ltd. (KMDA) Extends Glassia Agreement With Baxter International, Inc. (BAX) 9/29/2014 6:31:15 AM
Kamada Ltd. (KMDA) Reports Final Results From Phase 2/3 Clinical Trial Of Inhaled Alpha-1 Antitrypsin To Treat Alpha-1 Antitrypsin Deficiency 9/4/2014 11:38:00 AM
Kamada Ltd. (KMDA) Reports Second Quarter Financial Results 8/14/2014 8:10:08 AM
Kamada Ltd. (KMDA) To Host Second Quarter Financial Results Conference Call On Thursday, August 14, 2014 8/6/2014 9:27:49 AM
Kamada Ltd. (KMDA) Crashes After Key Trial Failure 5/16/2014 7:57:40 AM
Kamada Ltd. (KMDA.TA) To Announce Results From Phase 2/3 Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency On May 16 5/15/2014 9:23:47 AM
Kamada Ltd. (KMDA.TA) Reports First Quarter Financial Results 5/8/2014 9:27:08 AM
Kamada Ltd. (KMDA.TA) Announces Significantly Improved Infusion Rate For Glassia® 4/24/2014 6:59:59 AM
123456789